Physician profile
Andrew E Katz
NPI 1548237951
$11,890.70
in general payments reported to CMS, 2019-2025
34 companies · $2,518 in 2025
The $2,518 reported for 2025 was more than what 84% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $861 · 2021: $1,455 · 2022: $1,662 · 2023: $1,746 · 2024: $2,303 · 2025: $2,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,548 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,547.78 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,427.73 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,234.74 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $788.81 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $628.16 | 2019-2025 | Xifaxan, Trulance |
| Enterra Medical, INC. | $487.79 | 2023-2025 | |
| Gilead Sciences, INC. | $486.11 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $359.35 | 2021-2022 | |
| Lilly USA, LLC | $245.65 | 2024-2025 | Omvoh |
| Ironwood Pharmaceuticals, INC | $234.41 | 2020-2024 | Linzess |
| Regeneron Healthcare Solutions, INC. | $225.05 | 2022-2025 | Dupixent |
| Genzyme Corporation | $223.50 | 2022-2025 | |
| Aimmune Therapeutics, INC. | $168.57 | 2024-2025 | Zenpep |
| Medtronic, INC. | $158.37 | 2022-2025 | Interstim |
| Pfizer INC. | $131.10 | 2019-2025 | |
| Dova Pharmaceuticals | $124.03 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $114.92 | 2021-2024 | Zeposia |
| Qol Medical, LLC | $111.54 | 2023-2025 | Sucraid |
| Braintree Laboratories, INC. | $105.27 | 2019-2023 | Sutab, Suflave |
| Merck Sharp & Dohme LLC | $95.81 | 2019-2023 | Dificid |
| Vivus LLC | $75.87 | 2020-2025 | Pancreaze |
| Olympus America INC. | $72.86 | 2025 | Visiglide, Disposable Emr Kit |
| Romark Laboratories, Lc | $64.94 | 2019-2020 | |
| Ardelyx, INC. | $60.88 | 2025 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $49.80 | 2020-2022 | |
| Allergan, INC. | $43.95 | 2019-2020 | |
| Amgen INC. | $32.74 | 2023 | Avsola, Amjevita |
| Alfasigma USA, INC. | $22.15 | 2020 | |
| Shionogi INC | $20.92 | 2020 | |
| Phathom Pharmaceuticals, INC. | $20.14 | 2025 | Voquezna |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Capsovision, INC. | $15.53 | 2025 | Capsocam Plus |
| Echosens North America, INC. | $14.75 | 2025 | Fibroscan |
| Ferring Pharmaceuticals INC. | $12.79 | 2023 | Rebyota |
| Shire North American Group INC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.